Genzyme (GENZ) Announces FDA Marketing Approval for Synvisc-One; EC Approves Production of Myozyme at 4000L Scale
Tweet Send to a Friend
Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. FDA has granted marketing approval for Synvisc-One™ (hylan G-F 20), a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
